CI
RETA
CPMG Inc’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,896,901
| Closed | -$295M | – | 4 |
|
|
2023
Q2 | $295M | Hold |
2,896,901
| – | – | 59.26% | 1 |
|
|
2023
Q1 | $263M | Hold |
2,896,901
| – | – | 53.13% | 1 |
|
|
2022
Q4 | $110M | Hold |
2,896,901
| – | – | 27.63% | 2 |
|
|
2022
Q3 | $72.8M | Hold |
2,896,901
| – | – | 14.28% | 2 |
|
|
2022
Q2 | $88M | Hold |
2,896,901
| – | – | 17.69% | 2 |
|
|
2022
Q1 | $94.9M | Hold |
2,896,901
| – | – | 15.92% | 2 |
|
|
2021
Q4 | $76.4M | Hold |
2,896,901
| – | – | 14.09% | 3 |
|
|
2021
Q3 | $291M | Hold |
2,896,901
| – | – | 32.14% | 2 |
|
|
2021
Q2 | $410M | Hold |
2,896,901
| – | – | 67.78% | 1 |
|
|
2021
Q1 | $289M | Hold |
2,896,901
| – | – | 55.24% | 1 |
|
|
2020
Q4 | $358M | Sell |
2,896,901
-166,666
| -5% | -$20.6M | 55.16% | 1 |
|
|
2020
Q3 | $298M | Hold |
3,063,567
| – | – | 49.63% | 1 |
|
|
2020
Q2 | $478M | Hold |
3,063,567
| – | – | 63.81% | 1 |
|
|
2020
Q1 | $442M | Hold |
3,063,567
| – | – | 76.81% | 1 |
|
|
2019
Q4 | $626M | Buy |
3,063,567
+40,218
| +1% | +$8.22M | 47.15% | 1 |
|
|
2019
Q3 | $243M | Hold |
3,023,349
| – | – | 27.14% | 1 |
|
|
2019
Q2 | $285M | Hold |
3,023,349
| – | – | 33.71% | 1 |
|
|
2019
Q1 | $258M | Hold |
3,023,349
| – | – | 30.83% | 1 |
|
|
2018
Q4 | $170M | Buy |
3,023,349
+110,826
| +4% | +$6.22M | 15% | 1 |
|
|
2018
Q3 | $238M | Hold |
2,912,523
| – | – | 16.57% | 1 |
|
|
2018
Q2 | $102M | Hold |
2,912,523
| – | – | 9.64% | 1 |
|
|
2018
Q1 | $59.7M | Hold |
2,912,523
| – | – | 6.68% | 1 |
|
|
2017
Q4 | $82.5M | Buy |
+2,912,523
| New | +$82.5M | 8.34% | 1 |
|